Alessandro Dinoto Selected Research

Alessandro Dinoto Research Topics

Disease

6	Multiple Sclerosis 10/2023 - 11/2020
5	Neoplasms (Cancer) 02/2024 - 03/2022
5	Neuromyelitis Optica (Devic's Disease) 01/2024 - 01/2022
4	Infections 01/2024 - 01/2022
4	COVID-19 01/2024 - 01/2022
4	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 01/2022
3	Encephalitis (Encephalitis, Rasmussen) 10/2023 - 10/2020
2	Leukocytosis (Pleocytosis) 10/2023 - 10/2023
2	Nervous System Diseases (Neurological Disorders) 03/2023 - 07/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 12/2022
2	Glioma (Gliomas) 07/2022 - 10/2020
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 12/2018
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2020 - 05/2019
1	Disease Progression 02/2024
1	Movement Disorders (Movement Disorder) 02/2024
1	Coronavirus Infections 01/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Brain Diseases (Brain Disorder) 10/2023
1	Motor Disorders 03/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Muscular Diseases (Myopathy) 01/2023
1	Neutropenia 12/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2022
1	Lymphoma (Lymphomas) 03/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Inflammation (Inflammations) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Merkel Cell Carcinoma 01/2022
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Gait Ataxia 01/2022
1	Autoimmune Diseases of the Nervous System 01/2022
1	Spasm (Spasms) 12/2021
1	Vomiting 01/2021
1	Transverse Myelitis (Necrotizing Myelitis) 01/2021
1	Adenocarcinoma 01/2021
1	Hiccup (Hiccups) 01/2021
1	Fatigue 11/2020
1	Seizures (Absence Seizure) 10/2020
1	Neurobehavioral Manifestations 10/2020
1	Motor Neuron Disease (Primary Lateral Sclerosis) 05/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2019
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 12/2018

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2024 - 05/2019
8	Myelin-Oligodendrocyte GlycoproteinIBA 01/2024 - 01/2022
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
5	Immunoglobulin G (IgG)IBA 01/2024 - 11/2022
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2022
3	AutoantibodiesIBA 10/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
2	Immunoglobulin M (IgM)IBA 01/2024 - 01/2023
2	Complement System Proteins (Complement)IBA 10/2023 - 01/2023
2	Rituximab (Mabthera)FDA Link 12/2022 - 10/2020
2	AntigensIBA 07/2022 - 03/2022
2	Leucine (L-Leucine)FDA Link 07/2022 - 10/2020
2	CytokinesIBA 01/2022 - 01/2022
2	Bortezomib (Velcade)FDA Link 01/2022 - 01/2021
1	SteroidsIBA 02/2024
1	Nucleocapsid ProteinsIBA 01/2024
1	Immunoglobulin A (IgA)IBA 01/2024
1	GadoliniumIBA 10/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Myelin-Associated GlycoproteinIBA 01/2023
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2023
1	ocrelizumabIBA 12/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2022
1	COVID-19 VaccinesIBA 07/2022
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Natalizumab (Tysabri)FDA Link 01/2022
1	NivolumabIBA 01/2022
1	Basiliximab FDA Link 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Dimethyl FumarateIBA 01/2022
1	daratumumabIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	tofacitinibIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	avelumabIBA 01/2022
1	ChemokinesIBA 01/2022
1	Aquaporins (Water Channels)IBA 01/2022
1	nabiximols (Sativex)IBA 12/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 12/2021
1	N-Methylaspartate (NMDA)IBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Ketamine FDA LinkGeneric 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	perampanelIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 11/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020

Therapy/Procedure

7	Immunotherapy 02/2024 - 01/2021
1	Duration of Therapy 01/2022
1	Therapeutics 01/2022
1	Injections 12/2021
1	Radiotherapy 01/2021
1	Contraindications 11/2020